GovChime
Notice ID: 9647db9ff73b470bbadf84b0b6ac4e15Combined Synopsis/Solicitation

Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of ASO treated Brain Organoids

Archived on August 6, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
July 15, 2024
Notice type
Combined Synopsis/Solicitation
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Place of performance
Frederick, MD, 21703
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75N95024Q00422
Notice ID
9647db9ff73b470bbadf84b0b6ac4e15

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is 75N95024Q00422 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures; and FAR Part 12 Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Poochon Scientific LLC, 5350 Partners Court, STE. C, Frederick, MD 21703 for the Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of ASO treated Brain Organoids. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The Therapeutic Development Branch (TDB) at the National Center for Advancing Translational Sciences (NCATS) plans to use brain organoids derived from patients specific induce pluripotent stem cells (iPSC) as a model system in vitro to test new hypothesis, and establish diseases hallmarks by Liquid Chromatography with tandem mass spectrometry (LC/MS/MS). Furthermore, it will use the model system with proteomic profiling to validate the efficacy of potential therapeutic treatment such as antisense oligonucleotides (ASO). See Attachment 1 - Statement of Work.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95024Q00422
  1. Combined Synopsis
  1. Combined SynopsisCurrentJul 15, 2024

    Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of ASO treated Brain Organoids

    Notice 9647db9ff73b470bbadf84b0b6ac4e15 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95024Q00422

Archive Date

Aug 6, 2024

Office Address

Bethesda, MD, 20892